Analyst
Handelsbanken
Equibles does not estimate personal net worth.
Matthias Hegblom is recorded as Analyst at Handelsbanken. Matthias Hegblom has spoken on 1 earnings call across 1 company, most recently for Swedish Orphan Biovitrum AB (publ) on February 5, 2026. The companies whose calls Matthias Hegblom spoke on are classified in the Healthcare sector.
“So firstly on RSV, I'm curious to better understand what's embedded in the guidance beyond the survey you referenced. So royalty rate is going up in the year, I guess we should assume 27 percent.”
Handelsbanken
Analyst
Transcript header (unverified)
Swedish Orphan Biovitrum AB (publ)
Drug Manufacturers - Specialty & Generic · Healthcare
Interim Report Q4 2025
Swedish Orphan Biovitrum AB (publ)
